M. Prata

Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.

E. D. de Almeida, M. Prata, 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

Haemoglobin and erythropoietin levels in polycystic kidney disease.

M. Bicho, E. D. de Almeida, M. Prata, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Dose Requirements among Hemodialysis Patients Treated with Darbepoetin-α or Epoetin-β

C. Schmid, B. Pereira, J. Hegbrant, 2007, Nephron Clinical Practice.

MODIFICATION OF ANTIHYPERTENSIVE EFFECT OF &bgr;-ADRENOCEPTOR-BLOCKING AGENTS BY INHIBITION OF ENDOGENOUS PROSTAGLANDIN SYNTHESIS

M. Prata, V. Durão, L. M. P. Gonçalves, 1977, The Lancet.

Why the incidence in dialysis in the Lisbon and Tagus Valley Region (LVTR) is two to three times higher than in other regions of the country

M. Prata, 2021, Portuguese Journal of Nephrology & Hypertension.

Prevalence of autosomal-dominant polycystic kidney disease in Alentejo, Portugal.

C. Pires, E. D. de Almeida, M. Prata, 2001, Kidney international.

Nephrocalcinosis induced by furosemide in an adult patient with incomplete renal tubular acidosis.

M. Prata, F. Domingos, A. Simões, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Survival in haemodialysis: is there a role for vascular access?

M. Mil-Homens, E. D. de Almeida, M. Prata, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.